Search Results

8 results matching 1 active filter

AdministrativeCommercialDecember 1, 2024

Streamlined medical necessity reviews: What you need to know for timely decisions

Products & ProgramsCommercialDecember 1, 2023

Benefit enhancements for CalPERS PPO members

Products & Programs CalPERSCommercialMarch 1, 2023

Change to nonparticipating mental health facility services reimbursement for CalPERS

Products & Programs CalPERSCommercialMarch 1, 2022

Benefit change for CalPERS PPO Members: Important updates on certain medications‐ bevacizumab (Avastin), epoetin alfa (Epogen and Procrit), filgrastim (Neupogen), pegfilgrastim (Neulasta), rituximab (Rituxan), and trastuzumab (Herceptin)

Products & Programs CalPERSCommercialJanuary 1, 2022

Reminder: Pharmacy benefit change for CalPERS PPO members, effective January 2022

Products & Programs CalPERSCommercialDecember 1, 2021

Provider Notification of Benefit Change for CalPERS PPO Members‐ bevacizumab (Avastin), epoetin alfa (Epogen and Procrit), filgrastim (Neupogen), pegfilgrastim (Neulasta), rituximab (Rituxan), and trastuzumab (Herceptin)

Products & Programs CalPERSCommercialDecember 1, 2021

Benefit plan updates effective January 1, 2022

Products & Programs CalPERSCommercialSeptember 1, 2021

Benefit plan updates, effective January 1, 2022